Zobrazit minimální záznam

dc.contributor.authorJiravská Godula, Bogna
dc.contributor.authorJiravský, Otakar
dc.contributor.authorPešová, Petra
dc.contributor.authorJelínek, Libor
dc.contributor.authorSovová, Markéta
dc.contributor.authorMoravcová, Katarína
dc.contributor.authorOžana, Jaromír
dc.contributor.authorHudec, Miroslav
dc.contributor.authorMiklík, Roman
dc.contributor.authorHečko, Jan
dc.contributor.authorŠkňouřil, Libor
dc.contributor.authorSovová, Eliška
dc.date.accessioned2024-01-23T12:50:46Z
dc.date.available2024-01-23T12:50:46Z
dc.date.issued2023
dc.identifier.citationJournal of Cardiovascular Development and Disease. 2023, vol. 10, issue 4, art. no. 183.cs
dc.identifier.issn2308-3425
dc.identifier.urihttp://hdl.handle.net/10084/151947
dc.description.abstractSudden cardiac death (SCD) is a leading cause of death among athletes, and those with a positive family history (FH) of SCD and/or cardiovascular disease (CVD) may be at increased risk. The primary objective of this study was to assess the prevalence and predictors of positive FH of SCD and CVD in athletes using four widely used preparticipation screening (PPS) systems. The secondary objective was to compare the functionality of the screening systems. In a cohort of 13,876 athletes, 1.28% had a positive FH in at least one PPS system. Multivariate logistic regression analysis identified the maximum heart rate as significantly associated with positive FH (OR = 1.042, 95% CI = 1.027–1.056, p < 0.001). The highest prevalence of positive FH was found using the PPE-4 system (1.20%), followed by FIFA, AHA, and IOC systems (1.11%, 0.89%, and 0.71%, respectively). In conclusion, the prevalence of positive FH for SCD and CVD in Czech athletes was found to be 1.28%. Furthermore, positive FH was associated with a higher maximum heart rate at the peak of the exercise test. The findings of this study revealed significant differences in detection rates between PPS protocols, so further research is needed to determine the optimal method of FH collection.cs
dc.language.isoencs
dc.publisherMDPIcs
dc.relation.ispartofseriesJournal of Cardiovascular Development and Diseasecs
dc.relation.urihttps://doi.org/10.3390/jcdd10040183cs
dc.rights© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution.cs
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/cs
dc.subjectsudden cardiac deathcs
dc.subjectathletecs
dc.subjectpreparticipation screeningcs
dc.titlePreparticipation screening of athletes: The prevalence of positive family historycs
dc.typearticlecs
dc.identifier.doi10.3390/jcdd10040183
dc.rights.accessopenAccesscs
dc.type.versionpublishedVersioncs
dc.type.statusPeer-reviewedcs
dc.description.sourceWeb of Sciencecs
dc.description.volume10cs
dc.description.issue4cs
dc.description.firstpageart. no. 183cs
dc.identifier.wos000977794700001


Soubory tohoto záznamu

Tento záznam se objevuje v následujících kolekcích

Zobrazit minimální záznam

© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution.
Kromě případů, kde je uvedeno jinak, licence tohoto záznamu je © 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution.